Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 14
Encontrada(s) 1 página(s)

Repisalud
Publicación Artículo científico (JournalArticle)

Tumor-derived pericytes driven by EGFR mutations govern the vascular and immune microenvironment of gliomas

  • Segura-Collar, Berta
  • Garranzo-Asensio, Maria
  • Herranz, Beatriz
  • Hernandez-SanMiguel, Esther
  • Cejalvo, Teresa
  • Casas, Bárbara S
  • Matheu, Ander
  • Pérez-Núñez, Ángel
  • Sepúlveda-Sánchez, Juan Manuel
  • Hernández-Laín, Aurelio
  • Palma, Verónica
  • Gargini, Ricardo
  • Sánchez-Gómez, Pilar
The extraordinary plasticity of glioma cells allows them to contribute to different cellular compartments in tumor vessels, reinforcing the vascular architecture. It was recently revealed that targeting glioma-derived pericytes, which represent a big percentage of the mural cell population in aggressive tumors, increases the permeability of the vessels and improves the efficiency of chemotherapy. However, the molecular determinants of this transdifferentiation process have not been elucidated. Here we show that mutations in epidermal growth factor receptor (EGFR) stimulate the capacity of glioma cells to function as pericytes in a BMX (bone marrow and X-linked) and SOX9-dependent manner. Subsequent activation of platelet-derived growth factor receptor beta (PDGFRβ) in the vessel walls of EGFR mutant gliomas stabilized the vasculature and facilitated the recruitment of immune cells. These changes in the tumor microenvironment conferred a growth advantage to the tumors but also rendered them sensitive to pericyte-targeting molecules such as ibrutinib or sunitinib. In the absence of EGFR mutations, high-grade gliomas were enriched in blood vessels but showed a highly disrupted blood-brain-barrier due to the decreased BMX/SOX9 activation and pericyte coverage, which led to poor oxygenation, necrosis, and hypoxia. Overall, these findingds identify EGFR mutations as key regulators of the glioma-to-pericyte transdifferentiation, highlighting the intricate relationship between the tumor cells and their vascular and immune milieu. Our results lay the foundations for a vascular-dependent stratification of gliomas and suggest different therapeutic vulnerabilities determined by the genetic status of EGFR.
Repisalud
Publicación Artículo científico (JournalArticle)

The EGFR-TMEM167A-p53 Axis Defines the Aggressiveness of Gliomas

  • Segura-Collar, Berta
  • Gargini, Ricardo
  • Tovar-Ambel, Elena
  • Hernandez-SanMiguel, Esther
  • Epifano, Carolina
  • Perez de Castro, Ignacio
  • Hernández-Laín, Aurelio
  • Casas-Tinto, Sergio
  • Sánchez-Gómez, Pilar
Despite the high frequency of EGFR and TP53 genetic alterations in gliomas, little is known about their crosstalk during tumor progression. Here, we described a mutually exclusive distribution between mutations in these two genes. We found that wild-type p53 gliomas are more aggressive than their mutant counterparts, probably because the former accumulate amplifications and/or mutations in EGFR and show a stronger activation of this receptor. In addition, we identified a series of genes associated with vesicular trafficking of EGFR in p53 wild-type gliomas. Among these genes, TMEM167A showed the strongest implication in overall survival in this group of tumors. In agreement with this observation, inhibition of TMEM167A expression impaired the subcutaneous and the intracranial growth of wild-type p53 gliomas, regardless of the presence of EGFR mutations. In the absence of p53 mutations, TMEM167A knockdown reduced the acidification of intracellular vesicles, affecting the autophagy process and impairing EGFR trafficking and signaling. This effect was mimicked by an inhibitor of the vacuolar ATPase. We propose that the increased aggressiveness of wild-type p53 gliomas might be due to the increase in growth factor signaling activity, which depends on the regulation of vesicular trafficking by TMEM167A.
Repisalud
Publicación Artículo científico (JournalArticle)

Blood-Brain Barrier Disruption: A Common Driver of Central Nervous System Diseases

  • Segura-Collar, Berta
  • Mata-Martínez, Pablo
  • Hernández-Laín, Aurelio
  • Sánchez-Gómez, Pilar
  • Gargini, Ricardo
The brain is endowed with a unique cellular composition and organization, embedded within a vascular network and isolated from the circulating blood by a specialized frontier, the so-called blood-brain barrier (BBB), which is necessary for its proper function. Recent reports have shown that increments in the permeability of the blood vessels facilitates the entry of toxic components and immune cells to the brain parenchyma and alters the phenotype of the supporting astrocytes. All of these might contribute to the progression of different pathologies such as brain cancers or neurodegenerative diseases. Although it is well known that BBB breakdown occurs due to pericyte malfunctioning or to the lack of stability of the blood vessels, its participation in the diverse neural diseases needs further elucidation. This review summarizes what it is known about BBB structure and function and how its instability might trigger or promote neuronal degeneration and glioma progression, with a special focus on the role of pericytes as key modulators of the vasculature. Moreover, we will discuss some recent reports that highlights the participation of the BBB alterations in glioma growth. This pan-disease analysis might shed some light into these otherwise untreatable diseases and help to design better therapeutic approaches.
Repisalud
Publicación Artículo científico (JournalArticle)

Controlled release microspheres loaded with BMP7 suppress primary tumors from human glioblastoma

  • Gonzalez-Gomez, Pilar
  • Crecente-Campo, Jose
  • Zahonero, Cristina
  • Fuente, Maria de la
  • Hernández-Laín, Aurelio
  • Mira, Helena
  • Sánchez-Gómez, Pilar
  • Garcia-Fuentes, Marcos
Glioblastoma tumor initiating cells are believed to be the main drivers behind tumor recurrence, and therefore therapies that specifically manage this population are of great medical interest. In a previous work, we synthesized controlled release microspheres optimized for intracranial delivery of BMP7, and showed that these devices are able to stop the in vitro growth of a glioma cell line. Towards the translational development of this technology, we now explore these microspheres in further detail and characterize the mechanism of action and the in vivo therapeutic potential using tumor models relevant for the clinical setting: human primary glioblastoma cell lines. Our results show that BMP7 can stop the proliferation and block the self-renewal capacity of those primary cell lines that express the receptor BMPR1B. BMP7 was encapsulated in poly (lactic-co-glycolic acid) microspheres in the form of a complex with heparin and Tetronic, and the formulation provided effective release for several weeks, a process controlled by carrier degradation. Data from xenografts confirmed reduced and delayed tumor formation for animals treated with BMP7-loaded microspheres. This effect was coincident with the activation of the canonical BMP signaling pathway. Importantly, tumors treated with BMP7-loaded microspheres also showed downregulation of several markers that may be related to a malignant stem cell-like phenotype: CD133(+), Olig2, and GFAPδ. We also observed that tumors treated with BMP7-loaded microspheres showed enhanced expression of cell cycle inhibitors and reduced expression of the proliferation marker PCNA. In summary, BMP7-loaded controlled release microspheres are able to inhibit GBM growth and reduce malignancy markers. We envisage that this kind of selective therapy for tumor initiating cells could have a synergistic effect in combination with conventional cytoreductive therapy (chemo-, radiotherapy) or with immunotherapy.
Repisalud
Publicación Artículo científico (JournalArticle)

Ocoxin Modulates Cancer Stem Cells and M2 Macrophage Polarization in Glioblastoma

  • Hernandez-SanMiguel, Esther
  • Gargini, Ricardo
  • Cejalvo, Teresa
  • Segura-Collar, Berta
  • Nuñez-Hervada, Paula
  • Hortigüela, Rafael
  • Sepúlveda-Sánchez, Juan Manuel
  • Hernández-Laín, Aurelio
  • Pérez-Núñez, Ángel
  • Sanz, Eduardo
  • Sánchez-Gómez, Pilar
Glioblastoma (GBM) is the most common and devastating primary brain tumor. The presence of cancer stem cells (CSCs) has been linked to their therapy resistance. Molecular and cellular components of the tumor microenvironment also play a fundamental role in the aggressiveness of these tumors. In particular, high levels of hypoxia and reactive oxygen species participate in several aspects of GBM biology. Moreover, GBM contains a large number of macrophages, which normally behave as immunosuppressive tumor-supportive cells. In fact, the presence of both, hypoxia and M2-like macrophages, correlates with malignancy and poor prognosis in gliomas. Antioxidant agents, as nutritional supplements, might have antitumor activity. Ocoxin® oral solution (OOS), in particular, has anti-inflammatory and antioxidant properties, as well as antitumor properties in several neoplasia, without known side effects. Here, we describe how OOS affects stem cell properties in certain GBMs, slowing down their tumor growth. In parallel, OOS has a direct effect on macrophage polarization in vitro and in vivo, inhibiting the protumoral features of M2 macrophages. Therefore, OOS could be a feasible candidate to be used in combination therapies during GBM treatment because it can target the highly resilient CSCs as well as their supportive immune microenvironment, without adding toxicity to conventional treatments.
Repisalud
Publicación Artículo científico (JournalArticle)

Preclinical Test of Dacomitinib, an Irreversible EGFR Inhibitor, Confirms Its Effectiveness for Glioblastoma.

  • Zahonero, Cristina
  • Aguilera, Pilar
  • Ramírez-Castillejo, Carmen
  • Pajares, Marta
  • Bolos, Victoria
  • Cantero, Diana
  • Pérez-Núñez, Ángel
  • Hernández-Laín, Aurelio
  • Sánchez-Gómez, Pilar
  • Sepúlveda, Juan Manuel
Glioblastomas (GBM) are devastating tumors in which there has been little clinical improvement in the last decades. New molecularly directed therapies are under development. EGFR is one of the most promising targets, as this receptor is mutated and/or overexpressed in nearly half of the GBMs. However, the results obtained with first-generation tyrosine-kinase inhibitors have been disappointing with no clear predictive markers of tumor response. Here, we have tested the antitumoral efficacy of a second-generation inhibitor, dacomitinib (PF299804, Pfizer), that binds in an irreversible way to the receptor. Our results confirm that dacomitinib has an effect on cell viability, self-renewal, and proliferation in EGFR-amplified ± EGFRvIII GBM cells. Moreover, systemic administration of dacomitinib strongly impaired the in vivo tumor growth rate of these EGFR-amplified cell lines, with a decrease in the expression of stem cell-related markers. However, continuous administration of the compound was required to maintain the antitumor effect. The data presented here confirm that dacomitinib clearly affects receptor signaling in vivo and that its strong antitumoral effect is independent of the presence of mutant receptor isoforms although it could be affected by the PTEN status (as it is less effective in a PTEN-deleted GBM line). Dacomitinib is being tested in second line for EGFR-amplified GBMs. We hope that our results could help to select retrospectively molecular determinants of this response and to implement future trials with dacomitinib (alone or in combination with other inhibitors) in newly diagnosed GBMs.
Repisalud
Publicación Artículo científico (JournalArticle)

Immune Profiling of Gliomas Reveals a Connection with IDH1/2 Mutations, Tau Function and the Vascular Phenotype

  • Cejalvo, Teresa
  • Gargini, Ricardo
  • Segura-Collar, Berta
  • Mata-Martínez, Pablo
  • Herranz, Beatriz
  • Cantero, Diana
  • Ruano, Yolanda
  • García-Pérez, Daniel
  • Pérez-Núñez, Ángel
  • Ramos, Ana
  • Hernández-Laín, Aurelio
  • Martín-Soberón, María Cruz
  • Sánchez-Gómez, Pilar
  • Sepúlveda-Sánchez, Juan Manuel
Background: Gliomas remain refractory to all attempted treatments, including those using immune checkpoint inhibitors. The characterization of the tumor (immune) microenvironment has been recognized as an important challenge to explain this lack of response and to improve the therapy of glial tumors. Methods: We designed a prospective analysis of the immune cells of gliomas by flow cytometry. Tumors with or without isocitrate dehydrogenase 1/2 (IDH1/2) mutations were included in the study. The genetic profile and the presence of different molecular and cellular features of the gliomas were analyzed in parallel. The findings were validated in syngeneic mouse models. Results: We observed that few immune cells infiltrate mutant IDH1/2 gliomas whereas the immune content of IDH1/2 wild-type tumors was more heterogeneous. Some of them contained an important immune infiltrate, particularly enriched in myeloid cells with immunosuppressive features, but others were more similar to mutant IDH1/2 gliomas, with few immune cells and a less immunosuppressive profile. Notably, we observed a direct correlation between the percentage of leukocytes and the presence of vascular alterations, which were associated with a reduced expression of Tau, a microtubule-binding protein that controls the formation of tumor vessels in gliomas. Furthermore, overexpression of Tau was able to reduce the immune content in orthotopic allografts of GL261 cells, delaying tumor growth. Conclusions: We have confirmed the reduced infiltration of immune cells in IDH1/2 mutant gliomas. By contrast, in IDH1/2 wild-type gliomas, we have found a direct correlation between the presence of vascular alterations and the entrance of leukocytes into the tumors. Interestingly, high levels of Tau inversely correlated with the vascular and the immune content of gliomas. Altogether, our results could be exploited for the design of more successful clinical trials with immunomodulatory molecules.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

High-fidelity Cas9-mediated targeting of KRAS driver mutations restrains lung cancer in preclinical models

  • Alvarez-Perez, Juan Carlos
  • Sanjuan-Hidalgo, Juan
  • Arenas, Alberto M.
  • Hernandez-Navas, Ivan
  • Benitez-Cantos, Maria S.
  • Andrades, Alvaro
  • Calabuig-Farinas, Silvia
  • Paz-Ares, Luis
  • Ferrer, Irene
  • Medina, Pedro P.
  • Jantus-Lewintre, Eloisa|||0000-0001-7395-4380
[EN] Missense mutations in the 12th codon of KRAS are key drivers of lung cancer, with glycine-to-cysteine (G12C) and glycine-to-aspartic acid (G12D) substitutions being among the most prevalent. These mutations are strongly associated with poor survival outcomes. Given the critical role of KRAS in lung cancer and other cancers, it remains as a major target for the development of new and complementary treatments. We have developed a CRISPR-High Fidelity (HiFi)-Cas9-based therapy strategy that can effectively and specifically target KRASG12C and KRASG12D mutants, avoiding KRASWT off-targeting and affecting KRAS downstream pathways, thereby significantly reducing tumorgenicity. The delivery of HiFiCas9 components via ribonucleoprotein particles (RNPs) and adenovirus (AdV) effectively abrogates cell viability in KRAS-mutant Non-Small Cell Lung Cancer (NSCLC) preclinical models, including 2D and 3D cell cultures, cell-derived xenografts (CDX), and patient-derived xenograft organoids (PDXO). Our in vitro studies demonstrate that HiFiCas9-based therapy achieves superior KRAS inhibition compared to Sotorasib and effectively circumvents certain resistance mechanisms associated with Sotorasib treatment. Moreover, in vivo delivery using adenoviral particles significantly suppresses tumor growth in preclinical NSCLC models. Collectively, our findings establish HiFiCas9 as an effective therapeutic strategy with promising clinical applications, especially if in vivo delivery methods are further optimized., P.P.M.'s laboratory is supported by the grants PID2021-126111OB-I00 and PID2024-159252OB-I00, funded by the MCIN/AEI/10.13039/501100011033 and by ERDF ("A way to make Europe"), the Spanish Association Against Cancer (LAB-AECC-2018), the Junta de Andalucia (PI-0203-2022 and PI-0228-2024), and the University of Granada (B-CTS-480-UGR20, C-EXP-051-UGR23, C-CTS-149-UGR23). J.S.-H. is supported by a grant from the Scientific Foundation of the Spanish Association Against Cancer in Granada (#PRDGR21428SANJ). J.C.A.-P. was supported by an MSCA-IF-EF-RI 837897 fellowship (Horizon 2020 Framework Programme). A.M.A. was supported by an FPU17/01258 fellowship. A.A. was supported by an FPU17/00067 fellowship (Spanish Ministry of Science, Innovation, and Universities) and by the Programa de Contratos Puente (Plan Propio 2022) of the University of Granada. M.S.B.-C. was supported by an FPU19/00576 fellowship (Spanish Ministry of Science, Innovation, and Universities). E.J.-L.'s laboratory is funded by the Spanish Association Against Cancer (PROYE18012ROSE), the Instituto de Salud Carlos III (PI22/01221), and CIBERONC (CB16/12/00350). We would like to thank Ms. Rosario Martin from Ecija for her donation to promote research into lung cancer. The authors acknowledge the support of the ROLUCAN Association (Rota Lucha Contra el Cancer) for facilitating this research, and the Ph.D program of Biochemistry and Molecular Biology of the University of Granada.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Improving nitrate-to-ammonia conversion efficiency on electrodeposited nickel phosphide via surface delta-FeOOH modification

  • Silva, Anelisse B.
  • Reis, Eduardo A.
  • Hu, Jiajun
  • Ribeiro, Caue
  • Mascaro, Lucia H.
  • Albero-Sancho, Josep|||0000-0002-4841-7206
  • García Gómez, Hermenegildo|||0000-0002-9664-493X
[EN] Electrocatalytic nitrate reduction to ammonia is an appealing and promising approach for recovering industry and agricultural wastewater. However, there is a lack of efficient electrocatalysts for NO3- conversion at low overpotentials and a range of nitrate concentrations, which could enable nitrogen recovery from various wastewater streams. Here, we report an affordable and efficient electrodeposited amorphous-Ni3P electrode modified with delta-FeOOH, forming a heterojunction catalyst that efficiently converts nitrate into ammonia. The optimum heterojunction performance achieved a high faradaic efficiency of 98% +/- 0.72 at -0.3 V vs. RHE with an NH3 production yield of 8.49 mg h-1 cm-2, ranking Ni3P/delta-FeOOH among the most active electrocatalysts so far reported for this process. Ni3P/delta-FeOOH showed good stability using ethyl cellulose as a green and fluoride-free binder without losing the superficial modification. Mechanistic studies by in situ Raman spectroscopy show that the role of delta-FeOOH is the stabilisation of the NOx intermediates. At the same time, Ni3P provides *H species available for NOx reduction, thus resulting in highly selective NO3 hydrogenation. In contrast, in the absence of delta-FeOOH, Ni3P exhibits significantly lower NH3 faradaic efficiency due to simultaneous H2 evolution. Therefore, the present results show the synergistic effect between delta-FeOOH and Ni3P in the electrocatalytic nitrate reduction, with delta-FeOOH playing a crucial role in stabilising the reaction intermediates and enhancing the ammonia selectivity., The authors are grateful for the sponsorship and financial support of FAPESP (#2017/11986-5, #2018/01258-5, #2020/11756-2, #2022/15742-1, #2021/12394-0 and # 2013/07296-2), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brazil (CAPES) - Finance Code 001, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq, grant number #152607/2022-6, #311769/2022-5, #405133/2023 and #406156/2022-0, and FINEP-Financiadora de Estudos e Projetos grant number #01.22.0179.00, #01.23.0645.00. Also financial support from the Spanish Ministry of Science and Innovation (CEX-2021-001230S and PDI2021-0126071-OB-CO21 funded by MCIN/AEI/10.13039/501100011033) and Generalitat Valenciana (Prometeo 2021/038 and Advanced Materials programme Graphica MFA/2022/023 with funding from European Union NextGenerationEU PRTR-C17.I1) is gratefully acknowledged.
RIO. Repositorio Institucional Olavide
Publicación Artículo científico (JournalArticle)

Nanosized Porphyrinic Metal–Organic Frameworks for the Construction of Transparent Membranes as a Multiresponsive Optical Gas Sensor

  • García Moscoso, Francisco Javier
  • Romero Guerrero, Juan Jesús
  • Rodriguez Lucena, David|||0000-0001-5308-3979
  • Pedrosa, Jose M.|||0000-0001-8750-6220
  • Carrillo Carrión, Carolina
The well-known and excellent colorimetric sensing capacity of porphyrins, along with the exceptional structural properties of metal–organic frameworks (MOFs), make porphyrin-based MOFs, such as PCN-222, ideal candidates for the construction of a chemical sensor based on absorbance. However, to the best of authors’ knowledge, no high-quality porphyrin-based MOF gas sensors have been developed to date, most likely due to the difficulties in: 1) preparing nanosized porphyrin-MOFs to minimize scattering in absorbance measurements; and 2) incorporating MOFs into transparent membranes for practical use. Herein, a simple and fast microwave-assisted method for preparing high-quality nanosized PCN-222 crystals and their metalated derivatives PCN-222(M) is reported to finely tune the sensing response. Next, the successful dispersion of these PCN-222(M) nanoparticles into poly(dimethylsiloxane) to create flexible and transparent membranes is demonstrated. This integration yields a multiresponsive optical gas sensor exhibiting excellent sensitivity and the ability to discriminate between various volatile organic compounds via pattern recognition identification.
RIO. Repositorio Institucional Olavide
Publicación Artículo científico (JournalArticle)

Exploiting Cross-Responsiveness of Fluorescent Interpenetrated Zirconium–Organic Frameworks Integrated in Polymeric Membranes as a Multi-Analyte Gas Sensor Array

  • García Moscoso, Francisco Javier
  • Rodriguez Lucena, David|||0000-0001-5308-3979
  • Romero Guerrero, Juan Jesús
  • Hamad, Said|||0000-0003-4148-2344
  • Carrillo Carrión, Carolina
  • Pedrosa, Jose M.|||0000-0001-8750-6220
In this paper, a series of Zr metal-organic frameworks, whose hexanuclear clusters of Zr are connected with luminescent rodlike dicarboxylic acids, are used for the construction of a sensor array to selectively detect various analyte vapors. The chemical functionalization of the ligand (HOOC[PE-aryl-EP]COOH) (which alternates phenylene(P) and ethynylene(E) units) through the aryl core, is focused on obtaining six Porous Interpenetrated Zirconium-Organic Frameworks (PIZOFs) with distinctive luminescent properties. Particularly, the synthesis of two new ligands (aryl = nitrobenzene;metal-organic frameworks aryl = pyrazine) enabled the preparation of new PIZOFs (UPO-1 and UPO-2) with submicron sizes, thanks to the use of a microwave-assisted synthetic method. The fluorescence properties of these two new PIZOFs, along with four others already reported, are thoroughly evaluated and noticeable changes are observed in their optical properties based on variations in the aryl core of the ligands. Furthermore, the presence of various volatile analyte vapors particularly modified their characteristic emission, resulting in multiple optical responses that are combined to achieve selectivity in detecting these analytes. Specifically, the construction of a fluorescent sensor array is proposed, incorporating the six PIZOFs into polyvinylidene-fluoride (PVDF) films, capable of producing unique identification patterns for each analyte by leveraging the cross-responsiveness of these sensing materials.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Combined in-silico and on-chip validation of pseudopalisade formation hypothesis in Glioblastoma

  • Martínez-González, Alicia
  • Ayuso, Jose Maria
  • Monge, Rosa
  • Virumbrales-Muñoz, Maria
  • Llamazares, Guillermo A.
  • Hernández-Laín, A.
  • Sánchez-Gómez, Pilar
  • Pérez-García, Victor
  • Fernández, Luis
  • Ochoa, Ignacio
Introduction: Hypercellular regions surrounding necrotic areas in glioblastoma (GBM), named pseudopalisades, are characteristic of these tumors and have been hypothesized to be waves of migrating GBM cells. These structures are thought to be induced by oxygen depletion caused by the accumulation of cells far from nutrient supplies (chronic hypoxia) and/or tumor-induced blood vessel occlusion (acute hypoxia). The universal appearance of these structures in GBM suggests that they may play an instrumental role in their spreading and invasion. However the validation of the mechanisms of pseudopalisade formation has remained challenging. Materials and methods: A mathematical model was developed incorporating the main mechanisms of pseudopalisade formation. Oxygen coming from straight vessels drives phenotype changes. A third phenotype was included accounting for hypoxic cells switching back to a more proliferative phenotype in regions of normoxia. Experiments were done by embedding different densities of U-251 MG cells within a collagen hydrogel in a custom-designed microfluidic device. By controlling the medium flow through lateral microchannels, we mimic and control blood-vessel obstruction events associated with this disease. Results: Nutrient and oxygen starvation triggered a strong migratory process leading to pseudopalisade generation in silico and in vitro. Also, cells at greatest distance from oxygen supply became hypoxic after a critical point in tumor growth was reached (due to increased metabolism) forming pseudopalisades both in silico and in vitro. All the elements included in the mathematical model were necessary to describe both types of phenomena pointing out to the insufficiency of the go-or-grow hypothesis to describe pseudopalisade formation on-chip. Conclusions: Using a combination of computational and experimental techniques, we proved the feasibility of the two hypotheses of pseudopalisade formation, driven by either acute or chronic hypoxia. Additionally, we verified the potential of microfluidic devices as advanced artificial systems capable of experimentally modeling nutrient and oxygen gradients during tumor evolution.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Development of a six-degree-of-freedom analog 3D tactile probe based on non-contact 2D sensors

  • Albajez, José Antonio
  • Velázquez, Jesús
  • Torralba, Marta
  • Díaz-Pérez, Lucía C.
  • Yagüe-Fabra, José Antonio
  • Aguilar, Juan José
In this paper, a six-degree-of-freedom analog tactile probe with a new, simple, and robust mechanical design is presented. Its design is based on the use of one elastomeric ring that supports the stylus carrier and allows its movement inside a cubic measuring range of ±3 mm. The position of the probe tip is determined by three low-cost, noncontact, 2D PSD (position-sensitive detector) sensors, facilitating a wider application of this probe to different measuring systems compared to commercial ones. However, several software corrections, regarding the size and orientation of the three LED light beams, must be carried out when using these 2D sensors for this application due to the lack of additional focusing or collimating lenses and the very wide measuring range. The development process, simulation results, correction models, experimental tests, and calibration of this probe are presented. The results demonstrate high repeatability along the X-, Y-, and Z-axes (2.0 µm, 2.0 µm, and 2.1 µm, respectively) and overall accuracies of 6.7 µm, 7.0 µm, and 8.0 µm, respectively, which could be minimized by more complex correction models.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Methicillin-resistant and methicillin-sensitive Staphylococcus aureus in pork industry workers, Catalonia, Spain

  • Quero, Sara|||0000-0002-6454-6358
  • Serras-Pujol, Marina
  • Párraga-Niño, Noemí|||0000-0003-0376-5036
  • Torres, Carmen
  • Navarro, Marian
  • Vilamala, Anna
  • Puigoriol, Emma
  • de los Ríos, Javier Diez
  • Arqué, Elisenda
  • Serra-Pladevall, Judit|||0000-0002-4798-2385
  • Romero, Alba
  • Molina, Daniel
  • Paredes, Roger|||0000-0002-6553-691X
  • Pedro Botet, Maria Luisa|||0000-0001-7252-3191
  • Reynaga, Esteban|||0000-0002-4069-6087
Methicillin-resistant S. aureus (MRSA) especially ST398, is a zoonotic agent. This study aimed to determine the prevalence of methicillin-susceptible S. aureus (MSSA) and MRSA among workers in the pork production chain. 659 workers associated with 123 pig farms, livestock transporters, one pig slaughterhouse, pork transporters and 23 pork butcheries were studied for S. aureus recovery, and all isolates were characterized (antibiotic resistance, MLST and spa -typing). The prevalence of S. aureus was 35.5%, 75.6% of isolates being MRSA. The prevalence of MRSA was 68.7% (149/217) among pig farm, 33.9% (19/56) livestock transporters, 2.9% (9/306) slaughterhouse, 0% in pork transporters (0/36) and butchery workers (0/44). Of the 234 S. aureus -positive workers, 100% (149/149) of pig farm workers, 82.6% (19/23) of livestock transporters, and 16.4% (9/55) of slaughterhouse workers carried MRSA isolates (p < 0.001). Of the workers who had contact with live swine, 61.8% (178/288) were S. aureus -positive, MRSA being detected in 96.1% of cases (p < 0.001). The most frequent lineage among MRSA were: ST398 (97.7%; 173/177) and ST1 (1.7%; 3/177); and among MSSA were ST30 (19.2%; 11/57) and ST5 (10.5%; 6/57). The most frequent spa -types among MRSA were t011 (93.8%, 166/177) and t1451 (2.25%, 4/177), and among MSSA: t084 (10.5%, 6/57) and t021 (7.0%, 4/57). All MRSA isolates showed resistance to tetracycline, 92.7% to clindamycin, 81.9% to erythromycin and 40.1% to cotrimoxazole. Pig industry workers having occupational contact with live animals present a high risk of colonization of MRSA, especially by MRSA-ST398. Prevention measures should be intensified in any employment sector involving live animals.